Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases.

Matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, play an important role in ischemic injury to the heart, yet it is not known if these MMPs are involved in the injury that occurs to the transplant kidney. We therefore studied the pharmacologic protection of transplant kidneys during ma...

Full description

Bibliographic Details
Main Authors: Michael A J Moser, Steve Arcand, Han-Bin Lin, Chris Wojnarowicz, Jolanta Sawicka, Tamalina Banerjee, Yigang Luo, Gavin R Beck, Patrick P Luke, Grzegorz Sawicki
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4915675?pdf=render
_version_ 1818013691054915584
author Michael A J Moser
Steve Arcand
Han-Bin Lin
Chris Wojnarowicz
Jolanta Sawicka
Tamalina Banerjee
Yigang Luo
Gavin R Beck
Patrick P Luke
Grzegorz Sawicki
author_facet Michael A J Moser
Steve Arcand
Han-Bin Lin
Chris Wojnarowicz
Jolanta Sawicka
Tamalina Banerjee
Yigang Luo
Gavin R Beck
Patrick P Luke
Grzegorz Sawicki
author_sort Michael A J Moser
collection DOAJ
description Matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, play an important role in ischemic injury to the heart, yet it is not known if these MMPs are involved in the injury that occurs to the transplant kidney. We therefore studied the pharmacologic protection of transplant kidneys during machine cold perfusion.Human kidney perfusates were analyzed for the presence of injury markers such as cytochrome c oxidase, lactate dehydrogenase, and neutrophil-gelatinase associated lipocalin (NGAL), and MMP-2 and MMP-9 were measured. The effects of MMP inhibitors MMP-2 siRNA and doxycycline were studied in an animal model of donation after circulatory determination of death (DCDD).Markers of injury were present in all analyzed perfusates, with higher levels seen in perfusates from human kidneys donated after controlled DCDD compared to brain death and in perfusate from kidneys with delayed graft function. When rat kidneys were perfused at 4°C for 22 hours with the addition of MMP inhibitors, this resulted in markedly reduced levels of MMP-2, MMP-9 and analyzed injury markers.Based on our study, MMPs are involved in preservation injury and the supplementation of preservation solution with MMP inhibitors is a potential novel strategy in protecting the transplant kidney from preservation injury.
first_indexed 2024-04-14T06:36:23Z
format Article
id doaj.art-4ed4548915da4c8aa1e4d87879f9ff57
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T06:36:23Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4ed4548915da4c8aa1e4d87879f9ff572022-12-22T02:07:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015750810.1371/journal.pone.0157508Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases.Michael A J MoserSteve ArcandHan-Bin LinChris WojnarowiczJolanta SawickaTamalina BanerjeeYigang LuoGavin R BeckPatrick P LukeGrzegorz SawickiMatrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, play an important role in ischemic injury to the heart, yet it is not known if these MMPs are involved in the injury that occurs to the transplant kidney. We therefore studied the pharmacologic protection of transplant kidneys during machine cold perfusion.Human kidney perfusates were analyzed for the presence of injury markers such as cytochrome c oxidase, lactate dehydrogenase, and neutrophil-gelatinase associated lipocalin (NGAL), and MMP-2 and MMP-9 were measured. The effects of MMP inhibitors MMP-2 siRNA and doxycycline were studied in an animal model of donation after circulatory determination of death (DCDD).Markers of injury were present in all analyzed perfusates, with higher levels seen in perfusates from human kidneys donated after controlled DCDD compared to brain death and in perfusate from kidneys with delayed graft function. When rat kidneys were perfused at 4°C for 22 hours with the addition of MMP inhibitors, this resulted in markedly reduced levels of MMP-2, MMP-9 and analyzed injury markers.Based on our study, MMPs are involved in preservation injury and the supplementation of preservation solution with MMP inhibitors is a potential novel strategy in protecting the transplant kidney from preservation injury.http://europepmc.org/articles/PMC4915675?pdf=render
spellingShingle Michael A J Moser
Steve Arcand
Han-Bin Lin
Chris Wojnarowicz
Jolanta Sawicka
Tamalina Banerjee
Yigang Luo
Gavin R Beck
Patrick P Luke
Grzegorz Sawicki
Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases.
PLoS ONE
title Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases.
title_full Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases.
title_fullStr Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases.
title_full_unstemmed Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases.
title_short Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases.
title_sort protection of the transplant kidney from preservation injury by inhibition of matrix metalloproteinases
url http://europepmc.org/articles/PMC4915675?pdf=render
work_keys_str_mv AT michaelajmoser protectionofthetransplantkidneyfrompreservationinjurybyinhibitionofmatrixmetalloproteinases
AT stevearcand protectionofthetransplantkidneyfrompreservationinjurybyinhibitionofmatrixmetalloproteinases
AT hanbinlin protectionofthetransplantkidneyfrompreservationinjurybyinhibitionofmatrixmetalloproteinases
AT chriswojnarowicz protectionofthetransplantkidneyfrompreservationinjurybyinhibitionofmatrixmetalloproteinases
AT jolantasawicka protectionofthetransplantkidneyfrompreservationinjurybyinhibitionofmatrixmetalloproteinases
AT tamalinabanerjee protectionofthetransplantkidneyfrompreservationinjurybyinhibitionofmatrixmetalloproteinases
AT yigangluo protectionofthetransplantkidneyfrompreservationinjurybyinhibitionofmatrixmetalloproteinases
AT gavinrbeck protectionofthetransplantkidneyfrompreservationinjurybyinhibitionofmatrixmetalloproteinases
AT patrickpluke protectionofthetransplantkidneyfrompreservationinjurybyinhibitionofmatrixmetalloproteinases
AT grzegorzsawicki protectionofthetransplantkidneyfrompreservationinjurybyinhibitionofmatrixmetalloproteinases